| ORIGINAL ARTICLE |
|
| Year : 2013 | Volume
: 32
| Issue : 3 | Page : 134-138 |
|
|
Clinical evaluation of Vrsya effect of Pūga Khanda on sexual health and seminal parameters
Pramod C Baragi1, Sathyanarayana Bhat2, PK Prajapati3, Umapati C Baragi4
1 Department of Rasashastra and Bhaishajya Kalpana, N. K. Jabshetty Ayurveda Medical College and Post Graduate Centre, Bidar, India
2 Muniyal Institute of Ayurveda Medical Sciences, Manipal, Karnataka, India
3 Institute for Post Graduate Teaching and Research in Ayurveda, Gujarat Ayurved University, Jamnagar, Gujarat, India
4 Department of Basic Principles, S.D.M. College of Ayurveda, Udupi, Karnataka, India
Correspondence Address:
Pramod C Baragi
#748, 'Charakalaya' Near Bus-Stand, Bagalkot Cross Road, Bijapur - 586 101, Karnataka
India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/0257-7941.122995
|
|
|
Background: Due to changes in life-style, the human beings are losing their Vr.s.yata- (virility). Bio-medicine hasn't been able to address this challenge. Hence, we see that many people seek the help of herbal medicines to get relief. In view of the above, it becomes necessary to provide potent formulations to address this ailment.
Objectives: The study was designed to evaluate the efficacy of Pūga Khan.d.a on seminal parameters and sexual health.
Materials and Methods: Pūga Khan.d.a has been mentioned as Vr.s.ya (aphrodisiac) in the 30 th chapter of Bhaiśajyaratnāvali. A simple-randomised, single-blinded, placebo-controlled study comparing this Pūga Khan.d.a preparation with a placebo was conducted in 52 patients attending O.P.D. of Department of Rasa Shastra and Bhaishajya Kalpana of Muniyal Institute of Ayurveda Medical Sciences, Manipal. An elaborative case taking Proforma was specially designed for this purpose incorporating all aspects of the disease in the Ayurvedic parlance. Both groups received either Pūga Khan.d.a or placebo, in empty stomach in the early morning with water, as per the randomisation plan for a period of 45 days. Patients were followed-upto 4 weeks, 43 patients (84%) had completed the trial and no adverse effects were reported. The assessment was done on the basis of changes in seminal parameters and sexual health parameters.
Results: A varying degree of improvement was observed in sexual parameters viz. duration of coitus (P<0.001), frequency of coitus (P<0.01), Sexual desire (P<0.05), penile erection (P<0.01), A significant improvement was seen in duration of coitus (P< 0.001) in the group treated by Pūga Khan.d.a.
Conclusion: The trial drug Pūga Khan.d.a was superior to placebo in reducing the mean sign and symptom score of seminal parameters and sexual health. |
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
